Another clinical study showed that the levels of key factors involved in parthanatos, such as PARP‐1, PAR, AIF, and MIF, were significantly increased in PAH patients, particularly in non‐survivors,127 which underscores the connection between vascular parthanatos and PAH pathogenesis. The gene discussed is MIF; the disease is pulmonary arterial hypertension.